Frontiers in Immunology (Feb 2024)
Corrigendum: Sudocetaxel Zendusortide (TH1902) triggers the cGAS/STING pathway and potentiates anti-PD-L1 immune-mediated tumor cell killing
Abstract
No abstracts available.Keywords
Frontiers in Immunology (Feb 2024)